Review ArticleReview

Historical Review of Glasses Used for Parenteral Packaging

Robert A. Schaut and W. Porter Weeks
PDA Journal of Pharmaceutical Science and Technology July 2017, 71 (4) 279-296; DOI: https://doi.org/10.5731/pdajpst.2016.007377

Reference

  1. 1.↵
    1. Manniche L.
    Sacred Luxuries: Fragrance, Aromatherapy, and Cosmetics in Ancient Egypt, 1st ed.; Cornell University Press: Ithica, NY, 1999.
  2. 2.↵
    1. Stern E. M.
    Roman Mold-blown Glass: The First through Sixth Centuries; L'Erma di Bretschneider: Rome, Italy, 1995.
  3. 3.↵
    1. North H. H.
    Ampuls. J. Am. Pharm. Assoc. 1915, 4 (5), 567–575.
    OpenUrl
  4. 4.↵
    1. Graedon T.
    This MS Medication Costs More Than $27 Million per Gallon. The People's Pharmacy 2013. Accessed September 23, 2016; available at http://www.peoplespharmacy.com/2013/09/30/per-gallon-cost-of-pricey-prescription-for-ms-adds-up-to-many-millions/.
  5. 5.↵
    The Most Valuable Substances in the World by Weight. The Telegraph (U.K.) 2016. Accessed September 23, 2016; available at http://www.telegraph.co.uk/business/2016/05/18/the-most-valuable-substances-in-the-world-by-weight/soliris/.
  6. 6.↵
    The Price of a Gallon (47 Liquids Compared). 2013. Accessed September 23, 2016; available at http://www.cockeyed.com/science/gallon/liquid.html.
  7. 7.↵
    1. Kuehn S.
    Clash of the Titans: Super-Rivals Glass and Plastic Square Off for Patient Safety. Pharmaceutical Manufacturing 2014, October, 3–9.
  8. 8.↵
    1. Shelby J.
    Introduction to Glass Science and Technology, 2nd ed.; Royal Society of Chemistry: Cambridge, U.K., 2005.
  9. 9.↵
    1. Biser B. F.,
    2. Koch J. A.
    Elements of Glass and Glass Making; Glass and Pottery Publishing Company: Pittsburgh, PA, 1899.
  10. 10.↵
    1. Kurkjian C. R.,
    2. Prindle W. R.
    Perspectives on the History of Glass Composition. J. Am. Ceram. Society 1998, 81 (4), 785–813.
    OpenUrl
  11. 11.↵
    1. Matson F. R.
    The Composition and Working Properties of Ancient Glasses. Journal of Chemical Education 1951, 28 (2), 6.
    OpenUrl
  12. 12.↵
    1. Brill R. H.
    Volume 1: Catalogue of Samples. Chemical Analyses of Early Glasses; The Corning Museum of Glass: Corning, NY, 1999.
  13. 13.↵
    1. Brill R. H.
    Volume 2: The Tables. Chemical Analyses of Early Glasses; The Corning Museum of Glass: Corning, NY, 1999.
  14. 14.↵
    1. Schaut R.
    Bottle Glass Composition Survey; Corning Incorporated: Corning, NY, 2013 [Not Published].
  15. 15.↵
    1. Griffenhagen G.,
    2. Bogard M.
    History of Drug Containers and Their Labels; American Institute of the History of Pharmacy: Madison, WI, 1999.
  16. 16.↵
    1. Macht D. I.
    The History of Intravenous and Subcutaneous Administration of Drugs. J. Am. Med. Assoc. 1916, LXVI (12), 856–860.
    OpenUrlCrossRef
  17. 17.↵
    1. McKearin G. S.,
    2. McKearin H.
    American Glass. Crown Publishers: New York, 1948.
  18. 18.↵
    1. Lockhart B.
    The Color Purple: Dating Solarized Amethyst Container Glass. Historical Archaeology 2006, 40 (2), 45–56.
    OpenUrl
  19. 19.↵
    1. Lewis M.,
    2. Cudmore W.
    Photo-kinetics of Sodium Hypochlorite Solutions. Proceedings of the Chemical Society 1912, 406, 288–289.
    OpenUrl
  20. 20.↵
    USP Committee of Revision. The Pharmacopoeia of the United States of America Sixth Decennial Revision; William Wood & Company: New York, 1880.
  21. 21.↵
    1. Everett J. D.,
    2. Everett A.
    1. Hovestadt H.
    Jena Glass and Its Scientific and Industrial Applications, Everett J. D., Everett A., Eds.; The MacMillan Company: New York, 1902.
  22. 22.↵
    ASTM E438-92: Standard Specification for Glasses in Laboratory Apparatus. ASTM: West Conshohocken, PA, 2006, p 2.
  23. 23.↵
    1. Vogel W.
    Chemistry of Glass; Wiley/American Ceramic Society: Hoboken, NJ, 1985; p 325.
  24. 24.↵
    1. Limousin S.
    Ampoules Hypodermiques. Nouveau Mode de Préparation des Solutions pour les Injections Hypodermiques. Bulletin Géneral de Thérapeutique Médicale et Chirurgicale 1886, 110 (7), 316–319.
    OpenUrl
  25. 25.↵
    1. Snyder R. K.,
    2. Gathercoal E. N.
    Methods Used in the Determination of the Alkalinity Imparted to Water by Ampul Glass. J. Am. Pharm. Assoc. 1937, 26 (4), 321–328.
    OpenUrl
  26. 26.↵
    1. Lackenbach F. I.
    Ampoules. California State Journal of Medicine 1910, 8 (9), 316–317.
    OpenUrl
  27. 27.↵
    Year Book of the American Pharmaceutical Association. The American Pharmaceutical Association: Scio, Ohio; 1912; p 621.
  28. 28.↵
    Anonymous Author. Institute of Chemistry: Glass Research. Analyst 1915, 40, 263–266.
    OpenUrl
  29. 29.↵
    1. Graham M. B.,
    2. Shuldiner A. T.
    Corning and the Craft of Innovation; Oxford University Press: New York, 2001.
  30. 30.↵
    1. Dyer D.,
    2. Gross D.
    The Generations of Corning: The Life and Times of a Global Corporation. Oxford University Press: New York, 2001.
  31. 31.↵
    1. Kraissl F.
    A History of the Chemical Apparatus Industry. Journal of Chemical Education 1933, 10 (9), 519.
    OpenUrl
  32. 32.↵
    1. Abendroth R. P.
    Development of a U.S.P. Type I Glass for the Pharmaceutical Industry. PDA J. Pharm. Sci. Technol. 1985, 39 (3), 112–114.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. LaMastro R.
    Personal communication (to R. Schaut), 12 August 2016.
  34. 34.
    1. Stratton S. W.
    1. Walker P. H.,
    2. Smither F. W.
    Comparative Tests of Chemical Glassware. In Technologic Papers of the Bureau of Standards, Stratton S. W., Government Printing Office: Washington, DC, 1918.
  35. 35.
    1. Hinson A. L.,
    2. Smith D.C.,
    3. Greene J. F.
    Changes in Distilled Water Stored in Glass Ampuls. J. Am. Ceram. Soc. 1947, 30 (7), 211–214.
    OpenUrl
  36. 36.
    1. Yamanaka S.,
    2. Akagi J.,
    3. Hattori M.
    Reaction of Pyrex Type Borosilicate Glass with Water in Autoclave. J. Non-Cryst. Solids 1985, 70 (2), 279–290.
    OpenUrl
  37. 37.
    1. Schaut R.
    Vial Glass Composition Survey; Corning Incorporated: Corning, NY, 2014 [Not Published].
  38. 38.↵
    1. Boltres B.,
    2. Tratzky S.,
    3. Kass C.,
    4. Eichholz R.,
    5. Naß P.
    There Is Still Room for Improvement: Presentation of a Neutral Borosilicate Glass with Improved Chemical Stability for Parenteral Packaging. PDA J. Pharm. Sci. Technol. 2016, 70 (4), 346–352.
    OpenUrlAbstract/FREE Full Text
  39. 39.
    1. Volf M. B.
    Neutral Glasses. In Technical Glasses; Pitman: London U.K., pp 223–250.
  40. 40.↵
    1. Bacon F. R.
    The Chemical Durability of Silicate Glass, Part One. The Glass Industry 1968, 49 (8), 438–446.
    OpenUrl
  41. 41.↵
    1. Miller G. L.,
    2. Sullivan C.
    Machine-Made Glass Containers and the End of Production for Mouth-Blown Bottles. Historical Archaeology 1984, 18 (2), 83–96.
    OpenUrl
  42. 42.↵
    1. Miller G. L.,
    2. Pacey A.
    Impact of Mechanization in the Glass Container Industry: The Dominion Glass Company of Montreal. Historical Archaeology 1985, 19 (1), 38–50.
    OpenUrl
  43. 43.↵
    1. Kimble E. E.,
    2. Levis J. M.
    Vial-Necking Machine. U.S. Patent 1,009,418, 1911.
  44. 44.↵
    1. King D. B.
    Machine for Necking Vials or Bottles. U.S. Patent 1,489,837, 1924.
  45. 45.↵
    1. Zauner O.
    Tool for Shaping Glass Vials. U.S. Patent 2,952,943, 1960.
  46. 46.↵
    1. Zauner O.
    Apparatus for Forming Mouth Portions of Small Glass Containers. U.S. Patent 3,202,495, 1965.
  47. 47.↵
    1. Nema S.,
    2. Ludwig J. D.
    1. Swift R.
    Glass Containers for Parenteral Products. In Pharmaceutical Dosage Forms—Parenteral Medications, 3rd ed.; Nema S., Ludwig J. D., Eds.; Informa Healthcare: New York, 2012; Vol. 1, pp 287–304.
    OpenUrl
  48. 48.↵
    1. Sacha G. A.,
    2. Saffell-Clemmer W.,
    3. Abram K.,
    4. Akers M. J.
    Practical Fundamentals of Glass, Rubber, and Plastic Sterile Packaging Systems. Pharm. Dev. Technol. 2010, 15 (1), 6–34.
    OpenUrlPubMed
  49. 49.↵
    1. Troy D. B.,
    2. Beringer P.
    1. Akers M. J.
    Parenteral Preparations. Remington: The Science and Practice of Pharmacy, 21st ed.; Troy D. B., Beringer P., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, 2006; pp 802–825.
  50. 50.↵
    Food and Drug Administration. Advisory to Drug Manufacturers: Formation of Glass Lamellae in Certain Injectable Drugs. Food and Drug Administration: Silver Spring, MD, 2011.
  51. 51.↵
    1. Clark D. E.,
    2. Zoitos B. K.
    1. White W. B.
    Theory of Corrosion of Glass and Ceramics. In Corrosion of Glass, Ceramics and Ceramic Superconductors: Principles, Testing, Characterization and Applications, Clark D. E., Zoitos B. K. Eds.; Noyes Publications: Park Ridge, NJ, 1992; pp 2–28.
  52. 52.↵
    1. Dimbleby V.
    Glass for Pharmaceutical Purposes. J. Pharm. Pharmacol. 1953, 5 (1), 969–989.
    OpenUrlPubMed
  53. 53.↵
    1. Foerster F.
    Further Knowledge of Chemical Behaviour of Glass. Investigations at Reichsanstalt. Berichte der deutschen chemischen Gesellschaft 1893, 26, 2915.
    OpenUrl
  54. 54.↵
    1. Foerster F.
    Actions of Acids on Glass. Investigations at Reichssanstalt. Berichte der deutschen chemischen Gesellschaft 1893, 26, 2998.
    OpenUrl
  55. 55.↵
    DIN12116. Testing the Resistance of Glass to Attack by Boiling Hydrochloric Acid Solution, and Classification. In DIN12116; Deutsches Institut fur Normung, 2001.
  56. 56.↵
    1. Foerster F.
    Chemical Behavior of Glass. Action of Solutions of Alkalis and Salts on Glass. Berichte der deutschen chemischen Gesellschaft 1892, 25, 2494.
    OpenUrl
  57. 57.↵
    ISO695. Glass—Resistance to Attack by a Boiling Aqueous Solution of Mixed Alkali - Method of Test and Classification. In ISO695; International Organization of Standardization, 1991; p 6.
  58. 58.↵
    1. Clark D. E.,
    2. Pantano C. G.,
    3. Hench L. L.
    Corrosion of Glass; Books for Industry and the Glass Industry, Division of Magazines for Industry Inc.: New York, 1979.
  59. 59.↵
    1. Mylius F.,
    2. Foerster F.
    The Action of Water on Glass Vessels for Chemical Use. Analyst 1892, 17, 10–11.
    OpenUrl
  60. 60.↵
    1. Kohlrausch F.
    Solubility of Some Glasses in Cold Water. Ann. d. Phys. u. Chem. 1891, 44, 577.
    OpenUrl
  61. 61.↵
    1. Mylius F.
    On Disturbances of Spirit Levels. Zeitschr. f. Instrum. 1888, 8, 267.
    OpenUrl
  62. 62.↵
    ISO719. Glass—Hydrolytic Resistance of Glass Grains at 98 °C—Method of Test and Classification. International Organization for Standardization, 1985.
  63. 63.↵
    ISO720. Glass—Hydrolytic Resistance of Glass Grains at 121 °C—Method of Test and Classification. International Organization for Standardization, 1985; pp 1–5.
  64. 64.↵
    USP Committee of Revision. <660> Glass Containers. The United States Pharmacopeia Thirty-ninth Revision, 2016.
  65. 65.↵
    Parke, Davis & Company. Manual of Therapeutics: Referring Especially to the Products and the Pharmaceutical and Biological Laboratories of Parke, Davis & Company; Parke, Davis & Co.: Detriot, MI, 1909.
  66. 66.↵
    American Pharmaceutical Association. The National Formulary; American Pharmaceutical Association: Washington, DC, 1926; Vol. V.
  67. 67.↵
    USP Committee of Revision. Containers for Injection. In The Pharmacopoeia of the United States of America Twelfth Revision; The Board of Trustees: Easton, PA, 1942.
  68. 68.↵
    1. Eakins M. N.
    Parenteral Products: Pharmacopeial Control of Containers, Storage and Distribution. In Pharmacopeial Forum (PF) 2011, 3, 4.
    OpenUrl
  69. 69.↵
    Pharmaceutical Technology Editors. Harmonization of Pharmacopoeial Standards Stresses on Delamination. PharmTech.com 2015. Accessed September 21, 2016; available at http://www.pharmtech.com/harmonization-pharmacopoeial-standards-stresses-delamination.
  70. 70.↵
    1. Tarrant C.
    Production and Properties of Glass Containers. Journal of the Society of Cosmetic Chemists 1962, 13 (1), 15–42.
    OpenUrl
  71. 71.↵
    1. Avis K. E.,
    2. Lachman L.,
    3. Lieberman H. A.
    The Theory and Practice of Industrial Pharmacy; M. Dekker: New York, 1986.
  72. 72.↵
    1. Bloomfield J. E.
    Recalls and FDA Warning Letters Associated with Glass Issues for Sterile Drug Products. PDA/FDA Glass Quality Conference, 2011, Arlington, VA.
  73. 73.↵
    1. DeGrazio F.,
    2. Paskiet D.
    Glass Breakage, Delamination and Compatibility with Biologics Have Boosted Interest in Novel Materials in Pharma Packaging. Contract Pharma 2012.
  74. 74.↵
    U.S. Department of Health and Human Services, et al. Guidance for Industry and FDA Staff: Glass Syringes for Delivering Drug and Biological Products: Technical Information to Supplement ISO11040-4, 2013.
  75. 75.↵
    1. Gould C.
    Lessons Learned from Glass Recalls. PDA/FDA Glass Quality Conference, 2012, Washington, DC.
  76. 76.↵
    1. Tawde S. A.
    Particulate Matter in Injectables: Main Cause for Recalls. J. Pharmacovigil. 2014, 3 (1), 1–2.
    OpenUrl
  77. 77.↵
    Auto-Injectors: Forward Thinking. Pharma Integrates 2015. Available at http://www.pharma-integrates.com/auto-injectors-forward-thinking/.
  78. 78.↵
    1. Deutschle G.
    Schott Fills a Need to Improve Efficiency. Cosmetic Business 2014, April 28. Available at https://www.cosmeticsbusiness.com/technical/article_page/Schott_fills_a_need_to_improve_efficiency/97826.
  79. 79.↵
  80. 80.↵
    1. Jin H.,
    2. Sciammerella C.,
    3. Lamberti Y. L.
    Advancement of Optical Methods in Experimental Mechanics, Volume 3: Conference Proceedings of the Society for Experimental Mechanics Series, Jin H., Sciammerella C., Lamberti Y. L., Eds.; Springer International Publishing: New York, 2013.
  81. 81.↵
    1. Jacoby M.
    New Applications For Glass Emerge. Chemical & Engineering News 2012, 90 (25), 34–36.
    OpenUrl
  82. 82.↵
    PDA Technical Report 43. Identification and Classification of Nonconformities in Molded and Tubular Glass Containers for Pharmaceutical Manufacturing: Covering Ampoules, Bottles, Cartridges, Syringes and Vials. 2013.
  83. 83.↵
    <1207> Package Integrity Evaluation—Sterile Products. The United States Pharmacopeia Thirty-ninth Revision; USP Committee of Revision, U.S. Pharmacopeial Convention: Rockville, MD, 2016; pp 7764–7772.
  84. 84.↵
    1. Wang S. A.,
    2. Tokars J. I.,
    3. Bianchine P. J.,
    4. Carson L. A.,
    5. Arduino M. J.,
    6. Smith A. L.,
    7. Hansen N. C.,
    8. Fitzgerald E. A.,
    9. Epstein J. S.,
    10. Jarvis W. R.
    Enterobacter cloacae Bloodstream Infections Traced to Contaminated Human Albumin. Clin. Infecti. Dis. 2000, 30 (1), 35–40.
    OpenUrl
  85. 85.↵
    1. Bhakdi S.,
    2. Krämer I.,
    3. Siegel E.,
    4. Jansen B.,
    5. Exner M.
    Use of Quantitative Microbiological Analyses to Trace Origin of Contamination of Parenteral Nutrition Solutions. Med. Microbiol. Immunol. 2012, 201 (2), 231–237.
    OpenUrlCrossRefPubMed
  86. 86.↵
  87. 87.↵
    1. Ennis R. D.,
    2. Pritchard R.,
    3. Nakamura C.,
    4. Coulon M.,
    5. Yang T.,
    6. Visor G. C.,
    7. Lee W. A.
    Glass Vials for Small Volume Parenterals: Influence of Drug and Manufacturing Processes on Glass Delamination. Pharm. Dev. Technol. 2001, 6 (3), 393–405.
    OpenUrlPubMed
  88. 88.↵
    American Pharmaceutical Association. The National Formulary. American Pharmaceutical Association: Washington, DC, 1916; Vol. IV.
  89. 89.↵
    1. Bacon F. R.,
    2. Burch O. G.
    Resistance of Glass Bottles to Neutral Alcoholic Solutions. J. Am. Ceramic Society 1940, 23 (5), 147–151.
    OpenUrl
  90. 90.↵
    1. Liebmann A. J.,
    2. Rosenblatt M.
    Tests for the Chemical Durability of Bottles. J. Am. Ceramic Society 1941, 24 (10), 328–337.
    OpenUrl
  91. 91.↵
    1. Akagi S.
    Formation of Solid Products in Alcoholic Solution Contained in Soda-Lime-Silica Glass Bottle. Yogyo Kyokaishi 1980, 88 (1017), 278–284.
    OpenUrl
  92. 92.↵
    1. Bacon F. R.,
    2. Burch O. G.
    Effect of Time and Temperature on Accelerated Chemical Durability Tests Made on Commercial Glass Bottles. J. Am. Ceramic Society 1940, 23 (1), 1–9.
    OpenUrl
  93. 93.↵
    1. Haines D.,
    2. et al
    ., Glass Delamination Mechanisms: An Update. 2012 PDA/FDA Glass Quality Conference, Washington DC, 2012.
  94. 94.↵
    1. Ogawa T.,
    2. Miyajima M.,
    3. Wakiyama N.,
    4. Terada K.
    Effects of Phosphate Buffer in Parenteral Drugs on Particle Formation from Glass Vials. Chem. Pharm. Bull. 2013, 61 (5), 539–545.
    OpenUrlPubMed
  95. 95.↵
    1. Guadagnino E.,
    2. Zuccato D.
    Delamination Propensity of Pharmaceutical Glass Containers by Accelerated Testing with Different Extraction Media. PDA J. Pharm. Sci Technol. 2012, 66 (2), 116–125.
    OpenUrlAbstract/FREE Full Text
  96. 96.↵
    1. Roseman T. J.,
    2. Brown J. A.,
    3. Scothorn W. W.
    Glass for Parenteral Products: A Surface View Using the Scanning Electron Microscope. J. Pharm. Sci. 1976, 65 (1), 22–9.
    OpenUrlPubMed
  97. 97.↵
    1. Rupertus V.,
    2. Hladik B.,
    3. Rothhaar U.,
    4. Scheumann V.
    A Quick Test To Monitor the Delamination Propensity of Glass Containers. PDA J. Pharm. Sci. Technol. 2014, 68 (4), 373–380.
    OpenUrlAbstract/FREE Full Text
  98. 98.↵
    1. Bankston T.
    Glass Delamination: Part I. Considerations for Primary Containers. BD Medical—Webinar. 25 August 2011. Available at: http://us.meeting-stream.com/bectondickinsonandcompany_082511
  99. 99.↵
    1. Sanga S. V.
    Review of Glass Types Available for Packaging Parenteral Solutions. J. Parenter. Drug Assoc. 1979, 33 (2), 61–67.
    OpenUrlPubMed
  100. 100.↵
    1. Iacocca R. G.
    Medical Interactions with Glass Packaging Surfaces. Processing, Properties, and Applications of Glass and Optical Materials: Ceramic Transactions 2012, 231, 77–83.
    OpenUrl
  101. 101.↵
    1. Iacocca R. G.,
    2. Toltl N.,
    3. Allgeier M.,
    4. Bustard B.,
    5. Dong X.,
    6. Foubert M.,
    7. Hofer J.,
    8. Peoples S.,
    9. Shelbourn T.
    Factors Affecting the Chemical Durability of Glass Used in the Pharmaceutical Industry. AAPS PharmSciTech 2010, 11 (3), 1340–1349.
    OpenUrlPubMed
  102. 102.↵
    1. Iacocca R. G.,
    2. Allgeier M.
    Corrosive Attack of Glass by a Pharmaceutical Compound. J. Mater. Sci. 2007, 42 (3), 801–811.
    OpenUrl
  103. 103.↵
    1. Iacocca R. G.
    The Causes and Implications of Glass Delamination. Pharm. Technol. 2011, 35 (11), S6–S9.
    OpenUrl
  104. 104.↵
    1. Cerdian-Diaz J.,
    2. Fitzgerald M.
    Improving Chemical Durability and Resistance to Corrosion/Delamination through Chemistry Enhancement in Glass Manufacturing. PDA/FDA Glass Quality Conference, Arlington, VA, 2011.
  105. 105.↵
    Nippon Electric Glass. Press Release: Two New Materials of Glass Tubing for Pharmaceutical Containers Developed. Online 25 March 2015.
  106. 106.↵
    1. Schaut R. A.,
    2. Peanasky J. S.,
    3. DeMartino S. E.,
    4. Schiefelbein S. L.
    A New Glass Option for Parenteral Packaging. PDA J. Pharm. Sci. Technol. 2014, 68 (5), 527–534.
    OpenUrlAbstract/FREE Full Text
  107. 107.↵
    1. Brix P.
    Boron-Free Glass. U.S. Patent 8,629,072, 2014.
  108. 108.↵
    1. Weikart C.,
    2. Langer R.,
    3. Klibanov A.
    Novel Primary Containers for Parenteral Drugs. PDA/FDA Glass Quality Conference, Washington, D.C., 2012.
  109. 109.↵
    1. Rong T.,
    2. Conzone S.,
    3. Panchula M. L.
    Fused Quartz Tubing for Pharmaceutical Packaging. U.S. Patent Application 13/391,527 2010.
  110. 110.↵
    1. Reisse A.
    1. Reisse A.
    Schott Type I Plus—Solution for Delamination-Resistant Primary Packaging. In Pharmaceutical Packaging Newsflash; Reisse A. Ed.; 2012.
  111. 111.↵
    U.S. Pharmacopeia. Executive Summary of Packaging and Distribution Expert Committee Meeting. 22 June 2016; available at http://www.usp.org/sites/default/files/usp_pdf/EN/expert-committees/2015-06-22-23_gcpd_ec_meeting_execsumm.pdf.
Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Historical Review of Glasses Used for Parenteral Packaging
Robert A. Schaut, W. Porter Weeks
PDA Journal of Pharmaceutical Science and Technology Jul 2017, 71 (4) 279-296; DOI: 10.5731/pdajpst.2016.007377
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords